Evidence map›Paper›PMID 35134823›Full record

ArticleBriefings in bioinformatics2022

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases.

Xiao Yuan, Jing Wang, Bing Dai, Yanfang Sun, Keke Zhang, Fangfang Chen, Qian Peng, Yixuan Huang, Xinlei Zhang, Junru Chen and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Xiao YuanChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Jing WangChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Bing DaiChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Yanfang SunChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Keke ZhangChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Fangfang ChenChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Qian PengChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Yixuan HuangBeijing Geneworks Technology Co., Ltd., Beijing, China.
Xinlei ZhangReproductive & Genetics Hospital of Citic & Xiangya, Changsha, China.
Junru ChenGenetalks Biotech. Co., Ltd., Changsha, China.
Xilin XuGuangzhou Kingmed Center for Clinical Laboratory, Guangzhou, China.
Jun ChuanChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Wenbo MuGuangzhou Kingmed Center for Clinical Laboratory, Guangzhou, China.
Huiyuan LiChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Ping FangGuangzhou Kingmed Center for Clinical Laboratory, Guangzhou, China.
Qiang GongChangsha KingMed Center for Clinical Laboratory, Changsha, China.
Peng ZhangBeijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.ORCID 0000-0002-6218-1885
Kingmed Diagnostics · CNCapital Medical University · CNReproductive & Genetic Hospital CITIC-Xiangya · CN

Funding

Wellcome Trust
6 · The paper itself

Abstract

It's challenging work to identify disease-causing genes from the next-generation sequencing (NGS) data of patients with Mendelian disorders. To improve this situation, researchers have developed many phenotype-driven gene prioritization methods using a patient's genotype and phenotype information, or phenotype information only as input to rank the candidate's pathogenic genes. Evaluations of these ranking methods provide practitioners with convenience for choosing an appropriate tool for their workflows, but retrospective benchmarks are underpowered to provide statistically significant results in their attempt to differentiate. In this research, the performance of ten recognized causal-gene prioritization methods was benchmarked using 305 cases from the Deciphering Developmental Disorders (DDD) project and 209 in-house cases via a relatively unbiased methodology. The evaluation results show that methods using Human Phenotype Ontology (HPO) terms and Variant Call Format (VCF) files as input achieved better overall performance than those using phenotypic data alone. Besides, LIRICAL and AMELIE, two of the best methods in our benchmark experiments, complement each other in cases with the causal genes ranked highly, suggesting a possible integrative approach to further enhance the diagnostic efficiency. Our benchmarking provides valuable reference information to the computer-assisted rapid diagnosis in Mendelian diseases and sheds some light on the potential direction of future improvement on disease-causing gene prioritization methods.

Indexed as

Computational BiologyHigh-Throughput Nucleotide SequencingGenotypeHumansPhenotypeRetrospective Studiesbenchmarkinggene prioritizationHPOMendelian diseases

Identifiers

PMID35134823
PMCPMC8921623
OpenAlexW4206627019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.